Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
EP07.03 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Thymoma
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Thymoma
-
+
EP07.03-005 - MesoGraph: Graph Neural Networks for Weakly Supervised Cellular Profiling in the Subtyping of Malignant Mesothelioma Images
Presenter: Mark Eastwood- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-065 - Response to Systemic Anti-Cancer Therapy in Uncommon EGFR Mutations
Presenter: Hazel M O'Sullivan- Abstract
Loading... -
+
EP08.02-124 - Lorlatinib Treatment Related Adverse Events: Single Centre Real-World Experience in ALK and ROS1-driven NSCLC
Presenter: PARVIN BEGUM- Abstract
Loading... -
+
EP08.02-171 - PRO-CTCAE Analysis of Mobocertinib in EGFR Exon 20 Insertion‒Positive Metastatic Non‒Small Cell Lung Cancer (NSCLC)
Presenter: Rosario Garcia- Abstract
Loading...
-
+
EP08.03 - Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
-
+
EP08.03-005 - HALT - Targeted Therapy with or without Dose-Intensified Radiotherapy in Oligo-Progressive Disease in Oncogene Addicted Lung Tumours
Presenter: Fiona McDonald- Abstract
Loading...
-
+
EP11.03 - Pathology - Tumour Biology
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Pathology - Tumour Biology
-
+
EP11.03-003 - Adenocarcinoma Grade Correlates with PD-L1 and TP53, but not EGFR/KRAS Status and Diagnostic Yield: Analysis of 346 Cases
Presenter: Yu Zhi Zhang- Abstract
Loading...
-
+
P1.12 - Management of Lung Cancer in the Era of COVID-19
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Management of Lung Cancer in the Era of COVID-19
-
+
P1.12-05 - Prediction of Clinically Significant Pathological Upstaging in Resected Lung Cancer: Insight from COVID-19 Pandemic (1st wave)
Presenter: Yu Zhi Zhang- Abstract
Loading...
-
+
ES25 - Clinical Issues with Immunotherapy in Non-small Cell Lung Cancer
- 16:00 - 17:00
- 8/08/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Education Session
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Moderators:Martin Reck, Sanjay Popat
-
+
Session Moderator
16:38 - 16:50 | Presenter: Martin Reck
- Abstract
Loading... -
+
Session Moderator
16:38 - 16:50 | Presenter: Sanjay Popat
- Abstract
Loading... -
+
ES25.01 - Session Introduction
16:00 - 16:01 | Presenter: Martin Reck
- Abstract
Loading... -
+
ES25.02 - Session Introduction
16:01 - 16:02 | Presenter: Sanjay Popat
- Abstract
Loading... -
+
ES25.03 - First-Line Choice in PD-L1 Positive Patients
16:02 - 16:14 | Presenter: Filiz Oezkan
- Abstract
Loading... -
+
ES25.04 - First-Line Choice in PD-L1 Negative Patients
16:14 - 16:26 | Presenter: Delvys Rodriguez-Abreu
- Abstract
Loading... -
+
ES25.05 - Second-Line Options in Immune-Pretreated Patients
16:26 - 16:38 | Presenter: Keunchil Park
- Abstract
Loading... -
+
ES25.06 - Immunotherapy in Oncogene-Addicted NSCLC
16:38 - 16:50 | Presenter: Francesco Passiglia
- Abstract
Loading... -
+
ES25.07 - Live Q&A
16:50 - 17:00
- Abstract
Loading...
-
+
MA12 - Pathology: Tumour Diagnostics
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Pathology
- Moderators:Aleks Ryska, Deepali Jain
-
+
MA12.09 - Frequency and Detectability of Uncommon EGFR Mutations in NSCLC
11:22 - 11:27 | Presenter: Hazel M O'Sullivan
- Abstract
Loading...
